Susumu Ogawa

2.6k total citations
57 papers, 1.8k citations indexed

About

Susumu Ogawa is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Susumu Ogawa has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Nephrology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Susumu Ogawa's work include Chronic Kidney Disease and Diabetes (10 papers), Blood Pressure and Hypertension Studies (8 papers) and Advanced Glycation End Products research (8 papers). Susumu Ogawa is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Blood Pressure and Hypertension Studies (8 papers) and Advanced Glycation End Products research (8 papers). Susumu Ogawa collaborates with scholars based in Japan, United States and France. Susumu Ogawa's co-authors include Sadayoshi Ito, Kazuhiro Nako, Takefumi Mori, Masashi Okamura, Kazuhisa Takeuchi, Miho Senda, Takuya Sakamoto, Tsuneo Ishizuka, Toshio Miyata and T. KATO and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Hypertension and Journal of the American Society of Nephrology.

In The Last Decade

Susumu Ogawa

56 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susumu Ogawa Japan	24	678	398	332	312	255	57	1.8k
Pierre‐Jean Saulnier France	21	427 0.6×	263 0.7×	247 0.7×	346 1.1×	167 0.7×	79	1.3k
Rosa Rosario United States	25	420 0.6×	234 0.6×	586 1.8×	254 0.8×	299 1.2×	44	2.2k
Pedro Cortés United States	25	326 0.5×	262 0.7×	1.1k 3.3×	769 2.5×	182 0.7×	89	2.5k
I Kinalska Poland	25	536 0.8×	273 0.7×	490 1.5×	163 0.5×	597 2.3×	118	2.2k
Chang‐Hsun Hsieh Taiwan	21	467 0.7×	136 0.3×	425 1.3×	125 0.4×	189 0.7×	88	1.5k
Claudia Lamina Austria	29	524 0.8×	519 1.3×	412 1.2×	224 0.7×	316 1.2×	108	2.4k
Chul‐Hee Kim South Korea	30	846 1.2×	324 0.8×	469 1.4×	96 0.3×	478 1.9×	126	2.3k
Andrzej S. Januszewski Australia	25	580 0.9×	171 0.4×	542 1.6×	83 0.3×	431 1.7×	84	2.2k
Michio Otsuki Japan	29	1.1k 1.6×	278 0.7×	521 1.6×	120 0.4×	383 1.5×	129	2.5k
Julie E. Goodwin United States	23	340 0.5×	167 0.4×	505 1.5×	214 0.7×	125 0.5×	39	1.4k

Countries citing papers authored by Susumu Ogawa

Since Specialization

Citations

This map shows the geographic impact of Susumu Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Ogawa more than expected).

Fields of papers citing papers by Susumu Ogawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Ogawa. The network helps show where Susumu Ogawa may publish in the future.

Co-authorship network of co-authors of Susumu Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Ogawa. A scholar is included among the top collaborators of Susumu Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Ogawa. Susumu Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamano, Hiroya, et al.. (2024). What is the low-temperature limit of zooxanthellate coral? A new northernmost record of <i>Oulastrea crispata</i> (Lamarck, 1816) at 38°46′N, Tsuruoka, Yamagata Prefecture, Japan. Galaxea Journal of Coral Reef Studies. 26(1). 52–53.

Ogawa, Susumu, Yusuke Ohsaki, Kazuhiro Nako, et al.. (2021). Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial. Diabetology International. 13(1). 209–219. 13 indexed citations

Ogawa, Susumu, et al.. (2017). The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabetics. Clinical and Experimental Nephrology. 21(6). 1044–1052. 4 indexed citations

Sato, Emiko, Takefumi Mori, Michihiro Satoh, et al.. (2016). Urinary angiotensinogen excretion is associated with blood pressure in obese young adults. Clinical and Experimental Hypertension. 38(2). 203–208. 8 indexed citations

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, & Sadayoshi Ito. (2015). Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes. BMJ Open Diabetes Research & Care. 3(1). e000097–e000097. 8 indexed citations

Haneda, Masakazu, Kazunori Utsunomiya, Daisuke Koya, et al.. (2014). A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. Clinical and Experimental Nephrology. 19(1). 1–5. 121 indexed citations

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2013). Compared with insulin glargine, insulin degludec narrows the day-to-day variability in the glucose-lowering effect rather than lowering blood glucose levels. Journal of Diabetes Mellitus. 3(4). 244–251. 7 indexed citations

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2012). Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitus. BMJ Open. 2(2). e000830–e000830. 40 indexed citations

Hu, Chunyan, Takefumi Mori, Yi Lu, et al.. (2012). Role of specific T-type calcium channel blocker R(−) efonidipine in the regulation of renal medullary circulation. Journal of Hypertension. 30(8). 1620–1631. 4 indexed citations

10.

Guo, Qi, Takefumi Mori, Yue Jiang, et al.. (2011). Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats. Hypertension Research. 35(1). 48–54. 19 indexed citations

11.

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2011). Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes. The Tohoku Journal of Experimental Medicine. 223(2). 133–135. 94 indexed citations

12.

Guo, Qi, Takefumi Mori, Yue Jiang, et al.. (2009). Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague–Dawley rats. Journal of Hypertension. 27(8). 1664–1671. 91 indexed citations

13.

Ishizuka, Tsuneo, Susumu Ogawa, Takefumi Mori, et al.. (2009). Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Research and Clinical Practice. 84(2). e21–e23. 41 indexed citations

14.

Ogawa, Susumu, Takefumi Mori, Kazuhiro Nako, & Sadayoshi Ito. (2008). Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy. Hypertension Research. 31(6). 1147–1155. 43 indexed citations

15.

Ogawa, Susumu, Takefumi Mori, Kazuhiro Nako, Tsuneo Ishizuka, & Sadayoshi Ito. (2008). Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 3(2). 362–368. 23 indexed citations

16.

Ogawa, Susumu, Kazuhisa Takeuchi, Takefumi Mori, et al.. (2007). Effects of Monotherapy of Temocapril or Candesartan with Dose Increments or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy. Hypertension Research. 30(4). 325–334. 39 indexed citations

17.

Ogawa, Susumu, Kazuhisa Takeuchi, Takefumi Mori, Kazuhiro Nako, & Sadayoshi Ito. (2006). SPIRONOLACTONE FURTHER REDUCES URINARY ALBUMIN EXCRETION AND PLASMA B‐TYPE NATRIURETIC PEPTIDE LEVLES IN HYPERTENSIVE TYPE II DIABETES TREATED WITH ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR. Clinical and Experimental Pharmacology and Physiology. 33(5-6). 477–479. 21 indexed citations

18.

Tanaka, Masami, et al.. (2002). Incidence and Treatment of Dysgeusia in Patients with Glossodynia. Acta Oto-Laryngologica. 122(4). 142–145. 19 indexed citations

19.

Soma, Jun, Takao Saito, Yoshio Taguma, et al.. (2000). High Prevalence and Adverse Effect of Hepatitis C Virus Infection in Type II Diabetic-Related Nephropathy. Journal of the American Society of Nephrology. 11(4). 690–699. 78 indexed citations

20.

Dohi, Kazuhiro, Masayuki Iwano, Atsushi Muraguchi, et al.. (1991). The prognostic significance of urinary interleukin 6 in IgA nephropathy.. PubMed. 35(1). 1–5. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact